Högskolan i Skövde

his.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Vif-induced APOBEC3G degradation as a novel drug target for therapeutics in HIV
Högskolan i Skövde, Institutionen för vård och natur.
2012 (Engelska)Självständigt arbete på avancerad nivå (magisterexamen), 20 poäng / 30 hpStudentuppsats (Examensarbete)
Abstract [en]

Apolipoprotein B mRNA-editing enzyme catalytic polypeptide (APOBEC3G) a cellular host defence factor known for its antiviral activity for HIV-1. The potency of APOBEC3G is greatly reduced due to its interaction with viral infectivity factor (Vif) encoded by HIV-1. The interaction of APOBEC3G with Vif is via the SCF-like E3 ubiquitin ligase comprising of Cullin5 and Elongins B and C through a SOCS (suppressor of cytokine signalling box)-box, which binds to Elongin C leading to degradation of APOBEC3G via the ubiquitin proteosome pathway. The interaction between ElonginC and SOCS box harbouring Vif may serve as a therapeutic target on which Bimolecular fluorescence complementation assay (BiFC) was designed. A transient and optimized cellular testing platform was established for high-throughput screening of potential antiviral compound libraries. The plasmids were designed wherein the fluorescent fragment Venus, was linked to Vif and Elongin C. The BiFC test system was validated using well characterised mutants of Vif and ElonginC based on fluorescence complementation. The quantification of the Vif-ElonginC interaction was done with BiFC where rationally designed compounds were screened. A small molecule FM173 was identified to be inhibiting the Vif-Elongin C interaction using this cellular assay. Taken together, an effective screening platform was established with screening assay quality factor (Z factor) of 0.52 making it an excellent assay for identification of novel anti-retroviral agents based on the Vif-ElonginC interaction.

Ort, förlag, år, upplaga, sidor
2012. , s. 24
Nyckelord [en]
HIV, APOBEC, Vif, ElonginC, BiFC.
Nationell ämneskategori
Naturvetenskap
Identifikatorer
URN: urn:nbn:se:his:diva-5881OAI: oai:DiVA.org:his-5881DiVA, id: diva2:527159
Externt samarbete
UNIVERSITÄT WÜRZBURG, Germany
Ämne / kurs
Molekylärbiologi
Utbildningsprogram
Molekylärbiologi - magisterprogram
Presentation
2012-05-01, P 201, Portalen.Kanikegränd 3A,, Skövde, Sweden, 09:00 (Engelska)
Uppsök
bio-/geovetenskap
Handledare
Examinatorer
Tillgänglig från: 2012-05-28 Skapad: 2012-05-17 Senast uppdaterad: 2012-05-28Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Av organisationen
Institutionen för vård och natur
Naturvetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar

urn-nbn

Altmetricpoäng

urn-nbn
Totalt: 108 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf